Results 191 to 200 of about 49,164 (249)

Development and characterization of anti-CXCR4 chimeric antigen receptor T cells. [PDF]

Transl Oncol
Seir G, Bubb QR, Sotillo E, Gruber T, Richards RM, Czechowicz A.   +5 more
europepmc   +1 more source

CXCR4-Targeted Nanotherapeutics: A Promising Approach for Liver Fibrosis and Hepatocellular Carcinoma Management. [PDF]

Int J Nanomedicine
Ullah A, Khan M, Zhang Y, Shafiq M, Ullah M, Abbas A, Ullah K, Xiangxiang X, Chen G, Diao Y.   +9 more
europepmc   +1 more source

Overcoming therapeutic challenges in acute myeloid leukemia: active targeting strategies by nano-drug delivery systems. [PDF]

J Transl Med
Tang Y, Li J, Ye W, Du Y, Zhang Y, Ye Y, Gong Y.   +6 more
europepmc   +1 more source

Endothelial von Hippel-Lindau gene deletion causes abnormal blood and lymphatic vasculature through ectopic activation of the HIF-CXCR4 axis. [PDF]

Development
Li W, Nakayama K, Sato R, Shimada R, Kubota Y, Mukouyama YS.   +5 more
europepmc   +1 more source

Neuroprotective effects of telmisartan in a harmaline-induced model of essential tremor: modulation of the renin-angiotensin system and inflammatory pathways. [PDF]

Front Pharmacol
Farrag SM, Emam AM, Kamel AS, Saad MA, Kortam MA, Sayed NH, Fathy N.   +6 more
europepmc   +1 more source

Coreceptor usage of plasma and cerebrospinal fluid-derived HIV-1 subtype C variants. [PDF]

Virol J
Sirkisson S, Zikhali N, Chang C, Ndung'u T, Sojane K, Ndlovu B.   +5 more
europepmc   +1 more source

Artemisinin-Related Therapeutic Strategies for Autoimmune Thyroiditis: Chemokine-Receptor Networks, Spatial Thyroid Biology, and Molecular Mechanisms. [PDF]

Drug Des Devel Ther
Sun Y, Yang X, Zhu Q, Yang R.
europepmc   +1 more source

Circulating eosinophils in patients with hypereosinophilic syndrome have heterogeneous immunophenotypes. [PDF]

J Allergy Clin Immunol Glob
Chhiba KD, Kasjanski R, Makiya MA, Brown T, Khoury P, Klion AD, Kuang FL.   +6 more
europepmc   +1 more source

Glucocorticoids and Neutrophil Biology: Impact on the Development of Resistance to Glucocorticoid Therapy.

Neuroimmunomodulation
Pacheco FS, da Rocha Mota RG, Pinho Jannini de Sá YA, Hogaboam CM, Castro-Faria-Neto HC, Carvalho VF.   +5 more
europepmc   +1 more source